Showing results (121-130 of 133) with videos related to
Sort By:
Pageof 14
BMC Psychiatry|June 3, 2014
Mental health related determinants of parenting stress among urban mothers of young children--results from a birth-cohort study in Ghana and Côte d'IvoireNan Guo, Carola Bindt, Marguerite Te Bonle, et al.Pediatric Blood & Cancer|February 8, 2014
Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastomaJohnnie K Bass, Jie Huang, Arzu Onar-Thomas, et al.Plos One|December 12, 2018
A randomized controlled trial of a transdiagnostic cognitive-behavioral intervention for Afro-descendants' survivors of systemic violence in ColombiaFrancisco J Bonilla-Escobar, Andrés Fandiño-Losada, Diana M Martínez-Buitrago, et al.Plos Medicine|January 25, 2012
A United Nations General Assembly Special Session for mental, neurological, and substance use disorders: the time has comeJudith K Bass, Thomas H Bornemann, Matthew Burkey, et al.Nature Genetics|February 10, 2015
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing lossHeng Xu, Giles W Robinson, Jie Huang, et al.Neuro-Oncology|March 22, 2025
Ototoxicity and Cognitive Outcomes among Very Young Children Treated for Brain Tumors: Findings from a Multisite, Prospective, Longitudinal TrialHeather M Conklin, Nicole A Salman, Johnnie K Bass, et al.Neuro-Oncology Advances|January 28, 2021
Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trialAnthony P Y Liu, Gang Wu, Brent A Orr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2019
Cognitive Implications of Ototoxicity in Pediatric Patients With Embryonal Brain TumorsTraci W Olivier, Johnnie K Bass, Jason M Ashford, et al.Neuro-Oncology|January 14, 2014
Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastomaJames G Gurney, Johnnie K Bass, Arzu Onar-Thomas, et al.JAMA Network Open|February 19, 2026
Long-Term Outcomes Associated With Posterior Fossa Syndrome in Survivors of Childhood MedulloblastomaSupriya Sarvode, Rikeenkumar Dhaduk, Yan Chen, et al.Pageof 14